#evaluate(de(' #AdditionalMetaTags# '))#
EarlySight is developing a medical device to help doctors detect and monitor
eye diseases at early stage thanks to unprecedented imaging of the eye. Many
eye diseases (e.g. AMD, glaucoma) are starting with the degeneration of the
retina cellular structure which is invisible to current examinations. Our instrument
is the first retinal camera that can observe the tissue degenerative process
associated with retinal diseases and detect its evolution. The instrument can
image the retina in a unique way and has a ten times more precise image than
the standard of care. According to eye doctors, it will enable early diagnosis,
precise monitoring, and better treatments by providing objective evidences of
diseases progression.
Three Geneva Life Sciences and one Mobility startup awarded FIF Funding (startupticker.ch)
Crowd-Finanzierung für nächste Entwicklungs- und Expansionsschritte (startupticker.ch)
Innosuisse recognizes startups envisioned to transform the medical sector (startupticker.ch)
Quatre startups de Genève récompensées par le FIF (startupticker.ch)
The 16 most promising medtech startups in 2022, according to investors (TOP 100)
Venture Leaders Medtech 2022: Captain’s blog by Oncobit CEO Claudia Scheckel (venturelab.swiss)
Venture Leaders Medtech: 10 Swiss medtech startups showcase cutting-edge innovations in Boston (venturelab.swiss)
Good Morning Startups 2022: Credit Suisse investors and TOP 100 startups connect over breakfast (venturelab.swiss)
EarlySight: The Venture Leader Medtech providing imaging for early signs of retinal diseases years ahead of standard practice (venturelab.swiss)
The road to Boston: The Venture Leaders Medtech 2022 kick-off their international roadshow (venturelab.swiss)
Venture Leaders Medtech 2022: 10 innovative startups will advance their global growth in Boston (startupticker.ch)
Venture Leaders Medtech 2022: 10 innovative startups will advance their global growth in Boston (venturelab.swiss)
EarlySight raises CHF 2.3 million to detect and treat retinal diseases (venturekick.ch)
MVP Cellularis Discovery launched
Seed round